Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
Status:
RECRUITING
Trial end date:
2026-03-11
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of THDBH120 injection compared with placebo in weight reduction in overweight or obese subjects after 26 weeks of treatment.